ReviewCurrent opinion in virology2023

MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases.

Stephan Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.